Q
ABBV icon

QVR’s AbbVie ABBV Stock Holding History

QVR’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,600
Closed -$565K – 2
2026
Q1 		$565K Buy
+2,600
New +$577K 0.02% 84
2023
Q1 		– Sell
-2,800
Closed -$453K – 6
2022
Q4 		$453K Sell
2,800
-37,900
-93% -$5.81M 0.05% 50
2022
Q3 		$5.46M Buy
40,700
+16,300
+67% +$2.34M 0.45% 30
2022
Q2 		$3.74M Sell
24,400
-39,200
-62% -$5.99M 0.27% 49
2022
Q1 		$10.3M Buy
+63,600
New +$9.24M 0.39% 44
2021
Q4 		– Sell
-16,900
Closed -$1.82M – 18
2021
Q3 		$1.82M Buy
16,900
+7,000
+71% +$800K 0.12% 134
2021
Q2 		$1.12M Buy
9,900
+6,200
+168% +$698K 0.11% 95
2021
Q1 		$400K Buy
3,700
+3,100
+517% +$332K 0.04% 67
2020
Q4 		$64K Buy
+600
New +$57.7K 0.01% 119

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
HPC
HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return
CRM
Cardano Risk Management Rotterdam, Netherlands $13B AUM 49.44% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

QVR's ABBV Position: Q1 2026 in Review

QVR sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 3,805 shares — an estimated $844K sold.

QVR first reported a position in ABBV in Q4 2020 and held it in 6 quarters. The position peaked at $2.81M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • QVR reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • QVR sold 3,805 AbbVie shares in Q1 2026, an estimated $844K.
  • QVR first reported a position in AbbVie in Q4 2020 and held it in 6 quarters.
  • QVR's AbbVie position peaked at $2.81M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on QVR's 13F filing for Q1 2026, filed 15 Apr 2026.